Skip to content

All Press Releases

PILA PHARMA PRESENTS TODAY AT REDEYE THEME: DIABETES

Malmö, 23 May 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present today at the Redeye Theme: Diabetes. We hereby invite interested parties and investors to follow the event. It will take place today, Thursday 23 May 2024 at 09:30 CEST. The presentation is held physically in Redeye's studio…

Read more

CEO Gustav H. Gram increases holding in Pila Pharma AB

 Malmö, 15 May 2024 Download the press release as PDF here Pila Pharma AB (publ) (FN STO: PILA) announces that newly appointed CEO Gustav H. Gram has purchased additional shares. The purchases occurred in two tranches: Friday May 10th, where 13.756 shares in the company were acquired. The shares were purchased at an average price of SEK 2,4615.___Monday May 13th, where 8.453 shares in…

Read more

PILA PHARMA RECEIVES AWARD OF INNOVATION GRANT

Malmö, 7 May 2024 Download the press release as PDF here Pila Pharma AB (publ) (FN STO: PILA) hereby informs that it has been awarded an innovation grant corresponding to a value of SEK 100.000 to sponsor a further developed IP strategy. The innovation grant is sponsored by the Swedish Innovation Agency, Vinnova, and has been handled via the local Incubator at Medeon Science…

Read more

Contact us

Subscription for press releases
Back To Top